NCT05739006View on ClinicalTrials.gov

Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies

PHASE1UnknownINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

June 21, 2022

Study Completion Date

August 31, 2023

Conditions
MelanomaNon Small Cell Lung Cancer
Interventions
DRUG

BCD-201

up to 8 treatment cycles

DRUG

Keytruda

up to 8 treatment cycles

Trial Locations (3)

197758

"State Budgetary Healthcare Institution Saint Petersburg Clinical Research and Practice Center for Specialized Medical Care (Oncology)", Saint Petersburg

Unknown

"Russian Cancer Research Center named after N.N. Blokhin of the Ministry of Health of the Russian Federation", Moscow

"Budgetary healthcare institution of the Omsk region Clinical oncological dispensary", Omsk

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY

NCT05739006 - Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies | Biotech Hunter | Biotech Hunter